fasting and glp 1 Dietary impact on stimulated GLP-1 secretion in different metabolic conditions – a narrative review Added Value to GLP-1 Receptor

A small portion is excreted unchanged by the kidneys

The key secondary outcomes included a change from baseline to 12 months in z -scores for the ADAS-Exec (ADAS-Cog and the Executive domain scores from the NTB), the incidence and severity of treatment-emergent adverse events or clinically important changes in safety assessments over 12 months

Lean loss is a normal consequence of large, rapid weight loss on any incretin drug

I vividly remember debating the GLP-1 market size with sell-side analysts around this time, and several contested the TAM was $30-50B, even though my conservative napkin math pointed to $100B-$300B3

MOTS-c with exercise treatment reduced myocardial MDA and increased p-AMPK significantly comparing to only exercise or MOTS-c alone